Atropine/Pralidoxime Chloride

阿托品/氯解磷定

Report date: 2022/04/27 20:00:29

Base Information

Drug NameAtropine/Pralidoxime Chloride
Drug Alias NamePralidoxime Chloride+Atropine阿托品+氯解磷定氯解磷定+阿托品atropine and pralidoxime chloride injectionatropine and pralidoxime chloride +[10] 
ClassificationSmall molecules
Mechanisms of ActionAcetylcholinesterase activatorsMuscarinic acetylcholine receptor antagonists
TargetsMuscarinic acetylcholine receptorAcetylcholinesterase
Therapy Area/IndicationsDrug intoxicationsOrganophosphate PoisoningPoisoning +[4] 
Global Approved IndicationsDrug intoxicationsDrug-Related Side Effects and Adverse Reactions
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2002/01/17
Country/TerritoryUnited States
CombinationsYes Atropine SulfatePralidoxime Chloride
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesMeridian Medical Technologies Inc
China Registration ClassN/A

Develop Information

Active CompaniesMeridian Medical Technologies LLC
Inactive CompaniesU.S. Army
Active IndicationsOrganophosphate PoisoningPoisoning
Inactive IndicationsDrug intoxicationsDrug-Related Side Effects and Adverse Reactions

Other Information

ATC CodeN/A
Related LinksN/A